SI-BONE (NASDAQ:SIBN) Releases Earnings Results, Beats Expectations By $0.05 EPS

SI-BONE (NASDAQ:SIBN) posted its quarterly earnings data on Monday. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05, Zacks reports. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. SI-BONE updated its FY 2025 guidance to EPS.

SI-BONE Stock Performance

Shares of SIBN stock opened at $17.47 on Tuesday. SI-BONE has a 1-year low of $11.70 and a 1-year high of $20.60. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $732.66 million, a price-to-earnings ratio of -18.99 and a beta of 1.17. The stock’s fifty day simple moving average is $15.73 and its 200-day simple moving average is $14.69.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on SIBN shares. Needham & Company LLC restated a “buy” rating and issued a $19.00 target price on shares of SI-BONE in a report on Monday, January 13th. Truist Financial lifted their target price on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $23.00.

Insider Activity

In other news, CFO Anshul Maheshwari sold 5,304 shares of SI-BONE stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $13.91, for a total transaction of $73,778.64. Following the transaction, the chief financial officer now owns 189,319 shares in the company, valued at approximately $2,633,427.29. The trade was a 2.73 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Anthony J. Recupero sold 3,670 shares of SI-BONE stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $13.90, for a total value of $51,013.00. Following the transaction, the insider now owns 222,814 shares in the company, valued at $3,097,114.60. This represents a 1.62 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 9,311 shares of company stock worth $130,356. 3.90% of the stock is owned by corporate insiders.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.